In this white paper, explore how we can redefine precision medicine:

• Early Diagnosis: Understand the power of antibody biomarkers in identifying chronic diseases at their onset.
• Treatment Tailoring: Learn how these biomarkers can predict individual treatment responses and mitigate the risk of adverse effects.
• Technological Edge: Delve into the precision of Sengenics’ patented KREX® technology for accurate antibody screening.
• Impacts on Research: See how antibody biomarkers are not just predictive tools but also key to unlocking disease pathways, essential for novel drug development.